|
Age (years, median ± IQR)
|
73 (66–79)
|
66 (62–72)
|
67 (36–78)
|
NS
|
|
Dysability at admission (N, %)
| | | | |
|
Mild
|
4 (21,1%)
|
56 (62,9%)
|
3 (75%)
|
0.001
|
|
Moderate
|
1 (5,3%)
|
16 (18,0%)
|
0 (0%)
| |
|
Severe
|
14 (73,7%)
|
17 (19,1%)
|
1 (25%)
| |
|
Neurologic symptoms (N, %)
|
18 (90,0%)
|
69 (75,0%)
|
2 (50%)
|
NS
|
|
Heamorrhagic cerebral lesions (N, %)
|
9 (45,0%)
|
25 (24,5%)
|
0 (0%)
|
NS
|
|
Site of cerebral lesion (N, %)
| | | | |
|
Basal nuclei
|
1 (5,3%)
|
4 (4,3%)
|
1 (25%)
|
NS
|
|
Cerebral lobes
|
12 (63,2%)
|
61 (65,6%)
|
2 (50%)
| |
|
Cerebellum
|
0 (0,0%)
|
3 (3,2%)
|
0 (0%)
| |
|
Multiple sites
|
6 (31,6%)
|
25 (26,9%)
|
1 (25%)
| |
